UK markets open in 5 hours 53 minutes

Coloplast A/S (0QBO.L)

LSE - LSE Delayed price. Currency in DKK
Add to watchlist
856.00+30.28 (+3.67%)
At close: 06:45PM BST
Currency in DKK

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.32
52-week change 30.13%
S&P500 52-week change 326.27%
52-week high 3991.80
52-week low 3737.40
50-day moving average 3888.19
200-day moving average 3848.94

Share statistics

Avg vol (3-month) 345.38k
Avg vol (10-day) 364.64k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 8141.99M
% held by insiders 135.00%
% held by institutions 129.65%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 321.00
Trailing annual dividend yield 32.54%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 25:1
Last split date 319 Dec 2012

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 19.45%
Operating margin (ttm)27.19%

Management effectiveness

Return on assets (ttm)10.51%
Return on equity (ttm)42.74%

Income statement

Revenue (ttm)25.53B
Revenue per share (ttm)115.24
Quarterly revenue growth (yoy)8.70%
Gross profit (ttm)N/A
EBITDA 7.83B
Net income avi to common (ttm)4.97B
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)8.40%

Balance sheet

Total cash (mrq)889M
Total cash per share (mrq)3.95
Total debt (mrq)24.51B
Total debt/equity (mrq)151.29%
Current ratio (mrq)0.60
Book value per share (mrq)72.05

Cash flow statement

Operating cash flow (ttm)2.28B
Levered free cash flow (ttm)3.4B